.

Browsing Gilbert and Rose-Marie Chagoury School of Medicine by Author "Fleming, Jason"

LAUR Repository

Browsing Gilbert and Rose-Marie Chagoury School of Medicine by Author "Fleming, Jason"

Sort by: Order: Results:

  • Borderline Resectable Pancreatic Cancer 
    Katz, Matthew; Pisters, Peter; Evans, Douglas; Sun, Charlotte; Lee, Jeffrey; Fleming, Jason; Vauthey, Jean-Nicolas; Abdalla, Eddie; Crane, Christopher (2015-11-17)
    Background Patients with borderline resectable pancreatic adenocarcinoma (PA) include those with localized disease who have tumor or patient characteristics that preclude immediate surgery. There is no optimal treatment ...
  • Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy 
    Tzeng, Ching-Wei; Fleming, Jason; Lee, Jeffrey; Xiao, Lianchun; Pisters, Peter; Vauthey, Jean-Nicolas; Abdalla, Eddie; Wolff, Robert; Varadhachary, Gauri; Fogelman, David; Crane, Christopher; Balachandran, Aparna; Katz, Matthew (2015-11-20)
    Background We previously introduced a classification system for patients with localized pancreatic adenocarcinoma that integrates assessments of tumor anatomy, cancer biology, and patient physiology. By means of this ...
  • Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer 
    Katz, Matthew; Wang, Huamin; Balachandran, Aparna; Bhosale, Priya; Crane, Christopher; Wang, Xuemei; Pisters, Peter; Lee, Jeffrey; Vauthey, Jean-Nicolas; Abdalla, Eddie; Wolff, Robert; Abbruzzese, James; Varadhachary, Gauri; Chopin-Laly, Xavier; Chamsangavej, Chulsip; Fleming, Jason (2015-11-20)
    Objectives To determine the influence of neoadjuvant chemoradiation and standardized dissection of the superior mesenteric artery upon the oncologic outcome of patients with localized pancreatic adenocarcinoma. Methods One ...
  • Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors 
    Gaur, Puja; Sceusi, Eric; Samuel, Shaija; Xia, Ling; Zhou, Yunfei; Lu, Jia; Tozzi, Federico; Lopez-Berestein, Gabriel; Vivas-Mejia, Pablo; Fleming, Jason; Abdalla, Eddie; Curley, Steven; Vauthey, Jean-Nicolas; Sood, Anil; Yao, James; Ellis, Lee (2015-11-19)
    Background & Aims Metastatic gastrointestinal neuroendocrine tumors (NETs) frequently are refractory to chemotherapy. Chemoresistance in various malignancies has been attributed to cancer stem cells (CSCs). We sought ...
  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma 
    Katz, Matthew; Wang, Huamin; Fleming, Jason; Sun, Charlotte; Hwang, Rosa; Wolff, Robert; Varadhachary, Gauri; Abbruzzese, James; Crane, Christopher; Krishnan, Sunil; Vauthey, Jean-Nicolas; Abdalla, Eddie; Lee, Jeffrey; Pisters, Peter; Evans, Douglas (2015-11-17)
    Introduction Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic adenocarcinoma (PC), but the use of multimodality therapy was uncommon in these series. We evaluated long-term ...
  • One Hundred Years After “Carcinoid” 
    Yao, James; Hassan, Manal; Phan, Alexandria; Dagohy, Cecile; Leary, Colleen; Mares, Jeannette; Abdalla, Eddie; Fleming, Jason; Vauthey, Jean-Nicolas; Rashid, Asif; Evans, Douglas (2015-11-17)
    Purpose Neuroendocrine tumors (NETs) are considered rare tumors and can produce a variety of hormones. In this study, we examined the epidemiology of and prognostic factors for NETs, because a thorough examination of neither ...
  • Post-Therapy Pathologic Stage and Survival in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemoradiation 
    Estrella, Jeannelyn; Rashid, Asif; Fleming, Jason; Katz, Matthew; Lee, Jeffrey; Wolff, Robert; Varadhachary, Gauri; Pisters, Peter; Abdalla, Eddie; Vauthey, Jean-Nicolas; Wang, Hua; Gomez, Henry; Evans, Douglas; Abbruzzese, James; Wang, Huamin (2015-11-20)
    BACKGROUND: Neoadjuvant chemoradiation before surgery is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, analysis of prognostic factors is limited for patients with PDAC treated with ...
  • Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors 
    Landry, Christine; Lin, Heather; Phan, Alexandria; Charnsangavej, Chusilp; Abdalla, Eddie; Aloia, Thomas; Vauthey, Jean-Nicolas; Katz, Matthew; Yao, James; Fleming, Jason (2015-11-20)
    Background Neuroendocrine tumors of the small intestine commonly metastasize to regional lymph nodes (LNs). Single-institution reports suggest that removal of LNs improves outcome, but comprehensive data are lacking. We ...
  • Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications 
    Tzeng, Ching-Wei; Katz, Matthew; Fleming, Jason; Pisters, Peter; Lee, Jeffrey; Abdalla, Eddie; Curley, Steven; Vauthey, Jean-Nicolas; Aloia, Thomas (2015-11-20)
    Background: Historically, liver surgeons have withheld venous thromboembolism (VTE) chemoprophylaxis due to perceived postoperative bleeding risk and theorized protective anticoagulation effects of a hepatectomy. The ...
  • Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation 
    Katz, Matthew; Varadhachary, Gauri; Fleming, Jason; Wolff, Robert; Lee, Jeffrey; Pisters, Peter; Vauthey, Jean-Nicolas; Abdalla, Eddie; Sun, Charlotte; Wang, Huamin; Crane, Christopher; Lee, Jeffrey; Tamm, Eric; Abbruzzese, James; Evans, Douglas (2015-11-19)
    Purpose The role of carbohydrate antigen (CA) 19-9 in the evaluation of patients with resectable pancreatic cancer treated with neoadjuvant therapy prior to planned surgical resection is unknown. We evaluated CA 19-9 as ...

Search LAUR


Advanced Search

Browse

My Account